PTN
PTN
AMEX · Biotechnology

Palatin Technologies Inc

$6.57
-0.29 (-4.23%)
Financial Highlights (FY 2026)
Revenue
7.67M
Net Income
-4,873,440
Gross Margin
97.8%
Profit Margin
-63.5%
Rev Growth
+39.6%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 97.8% 97.8% 59.4% 59.4%
Operating Margin -65.7% -59.2% 3.8% 3.7%
Profit Margin -63.5% -60.4% 2.8% 3.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 7.67M 5.50M 18.13M 17.61M
Gross Profit 7.50M 5.38M 10.76M 10.46M
Operating Income -5,042,094 -3,251,332 697.0K 644.8K
Net Income -4,873,440 -3,142,577 507.1K 519.2K
Gross Margin 97.8% 97.8% 59.4% 59.4%
Operating Margin -65.7% -59.2% 3.8% 3.7%
Profit Margin -63.5% -60.4% 2.8% 3.0%
Rev Growth +39.6% +39.6% +2.0% -8.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 11.13M 14.02M
Total Equity — — 13.72M 13.10M
D/E Ratio — — 0.81 1.07
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,005,831 -3,407,279 911.5K 901.4K
Free Cash Flow — — 739.6K 699.1K